Prospect811
Sign in Start prospecting →
Industry payments · Johnson & Johnson

Johnson & Johnson payments to clinicians, state by state.

In 2025, Johnson & Johnson reported $188.3M in general payments to 211,139 US clinicians, per CMS Open Payments data (excluding one-time buyouts). Pick a state for the full breakdown: payment mix, top products, specialties, and cities. No clinician is named on these pages.

By state

Pick your state.

States with fewer than 25 paid clinicians in the 2025 data aren't listed. The app tracks every state, every year, down to the clinician.

Alabama3,896 clinicians Alaska320 clinicians Arizona4,862 clinicians Arkansas2,366 clinicians California17,953 clinicians Colorado3,343 clinicians Connecticut2,695 clinicians Delaware711 clinicians Florida18,051 clinicians Georgia7,636 clinicians Hawaii649 clinicians Idaho1,063 clinicians Illinois7,445 clinicians Indiana5,097 clinicians Iowa1,649 clinicians Kansas2,021 clinicians Kentucky4,541 clinicians Louisiana4,430 clinicians Maine346 clinicians Maryland4,148 clinicians Massachusetts3,653 clinicians Michigan7,455 clinicians Minnesota1,480 clinicians Mississippi2,319 clinicians Missouri4,690 clinicians Montana429 clinicians Nebraska1,770 clinicians Nevada1,802 clinicians New Hampshire631 clinicians New Jersey6,547 clinicians New Mexico867 clinicians New York12,532 clinicians North Carolina7,048 clinicians North Dakota456 clinicians Ohio8,343 clinicians Oklahoma2,654 clinicians Oregon1,563 clinicians Pennsylvania9,417 clinicians Rhode Island671 clinicians South Carolina4,049 clinicians South Dakota661 clinicians Tennessee6,050 clinicians Texas17,411 clinicians Utah2,060 clinicians Vermont50 clinicians Virginia5,484 clinicians Washington2,790 clinicians Washington, D.C.653 clinicians West Virginia1,172 clinicians Wisconsin1,937 clinicians Wyoming230 clinicians
The trend

National general payments by year.

2025$188.3M · 211,139 clinicians
2024$171.2M · 203,234 clinicians
2023$159.8M · 187,767 clinicians
2022$158.5M · 191,426 clinicians
2021$132.6M · 169,373 clinicians
2020$117.6M · 96,838 clinicians
2019$255.6M · 146,818 clinicians
Where these numbers come from. Everything on this page is computed from CMS's public Open Payments (Sunshine Act) data for program year 2025. Federal law requires manufacturers and group purchasing organizations to report payments and transfers of value to physicians and other covered clinicians; CMS publishes the records each year. A reported payment is a disclosed financial relationship required by law. It is not evidence of anything improper, and it says nothing about whether a clinician uses, prefers, or prescribes any product. Totals are general payments only and exclude acquisition buyouts and debt forgiveness (one-time events, not working relationships). Research dollars are shown separately as associated funding: money tied to a study on which a clinician is named as recipient or principal investigator. It funds the study, not the person. Product rows count a payment toward every product named on it, across all payment types, so product rows do not add up to the total. Johnson & Johnson figures combine the 31 corporate entities that report under it, normalized so the whole company shows up as one. Clinicians whose federal enrollment record no longer lists a US practice state are not in state rollups. Prospect 811 organizes public data; it doesn't add to or alter it. Not affiliated with or endorsed by CMS. Full detail on the data page.

Every state. Every year. Every name.

Prospect 811 shows the clinicians behind these numbers, ranked by dollars and linked to their Medicare billing, in your exact territory. $79/month, no contract, 14-day refund.

Start prospecting →
Sign in with Google or a magic link.